Skip to content
Menu

Fate Therapeutics, Inc. FATE

Full chart Compare
Set alert

Price alert · FATE

All alert types
1.01 USD -0.04 (-3.81%)

Regular-session close

1.05 +0.04 +3.79%

After hours · Nov 19, 7:13 PM ET

1.01 Day range 1.07
0.95 52-week range 3.23
YTD
+3.06%
1 year
-3.81%

FATE revenue history

Revenue is income from the company’s ordinary business activities.

6,646,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-316,646,000-6,985,000-51.24%
FY 20242024-12-3113,631,000-49,902,000-78.55%
FY 20232023-12-3163,533,000-32,767,000-34.03%
FY 20222022-12-3196,300,00040,454,00072.44%
FY 20212021-12-3155,846,00024,412,00077.66%
FY 20202020-12-3131,434,00020,754,000194.33%
FY 20192019-12-3110,680,0005,940,000125.32%
FY 20182018-12-314,740,000634,00015.44%
FY 20172017-12-314,106,000-296,000-6.72%
FY 20162016-12-314,402,0001,971,00081.08%
FY 20152015-12-312,431,0002,431,000Not meaningful
FY 20142014-12-310-971,000-100.00%
FY 20132013-12-31971,000-1,699,000-63.63%
FY 20122012-12-312,670,0001,500,000128.21%
FY 20112011-12-311,170,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:03.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.